GE HealthCare Beats Q2 Profit Estimates on Strong Imaging Demand, Tariff Refund

GE HealthCare Technologies Inc. (GEHC) reported second-quarter earnings and revenue that surpassed Wall Street expectations, propelled by robust demand for its imaging and diagnostic products and a significant one-time tariff refund. The strong results sent the company's shares soaring in premarket trading on Wednesday.

Strong Demand and Tariff Refund Boost Results

For the three months ending June 30, GE HealthCare posted adjusted earnings of $1.13 per share, beating the average analyst estimate of $1.04, according to data compiled by LSEG. Revenue for the quarter came in at $5.30 billion, slightly ahead of the expected $5.26 billion.

The company's performance was driven by solid growth in its key segments. Sales in the Imaging division grew by 7.9%, while the Pharmaceutical Diagnostics unit posted an even stronger 15.6% increase in sales year-over-year.

Net income rose to $561 million from $486 million in the prior-year period. The bottom line was substantially boosted by a $129 million refund of tariffs that U.S. courts had previously ruled were illegally collected under the Trump administration.

Easing Investor Concerns

Ad

The positive report helps allay investor concerns about the medical device sector, which had been on edge after hospital operator HCA Healthcare recently warned of softening demand for surgical procedures. In response to the earnings beat, shares of GE HealthCare jumped 12% in premarket trading.

GE HealthCare's performance aligns with other major device makers like Abbott and Intuitive Surgical, which also recently beat quarterly estimates. This suggests resilient procedure volumes in specific areas despite broader hospital-level pressures.

Margin Pressures Persist

Despite the strong top-line growth, the company faced margin headwinds. Its adjusted core margin was 40 basis points lower than in the same period last year, which GE HealthCare attributed to persistent inflation affecting memory chips, oil, and freight costs.

The company also stated that "Global geopolitical instability, including the conflict in the Middle East, adversely impacted our costs, supply chains, and logistics during the second quarter." However, GE HealthCare maintained its previously issued annual profit forecast, signaling confidence in its ability to manage these ongoing costs.